Alcon EBITDA 2019-2024 | ALC
Alcon annual and quarterly EBITDA history from 2019 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Alcon EBITDA for the quarter ending December 31, 2024 was $705M, a 37.16% increase year-over-year.
- Alcon EBITDA for the twelve months ending December 31, 2024 was $2.639B, a 16.51% increase year-over-year.
- Alcon 2024 annual EBITDA was $2.639B, a 16.51% increase from 2023.
- Alcon 2023 annual EBITDA was $2.265B, a 27.03% increase from 2022.
- Alcon 2022 annual EBITDA was $1.783B, a 0.94% decline from 2021.
| Alcon Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $2,639 |
| 2023 | $2,265 |
| 2022 | $1,783 |
| 2021 | $1,800 |
| 2020 | $1,144 |
| 2019 | $1,269 |
| 2018 | $1,374 |
| Alcon Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-12-31 | $705 |
| 2024-09-30 | $642 |
| 2024-06-30 | $628 |
| 2024-03-31 | $664 |
| 2023-12-31 | $514 |
| 2023-09-30 | $610 |
| 2023-06-30 | $571 |
| 2023-03-31 | $570 |
| 2022-12-31 | $280 |
| 2022-09-30 | $469 |
| 2022-06-30 | $525 |
| 2022-03-31 | $509 |
| 2021-12-31 | $439 |
| 2021-09-30 | $453 |
| 2021-06-30 | $475 |
| 2021-03-31 | $433 |
| 2020-12-31 | $558 |
| 2020-09-30 | $301 |
| 2020-06-30 | $-67 |
| 2020-03-31 | $352 |
| 2019-12-31 | $310 |
| 2019-09-30 | $351 |
| 2019-06-30 | $308 |
| 2019-03-31 | $300 |
| 2018-12-31 | |
| 2018-09-30 | $388 |
| 2018-06-30 | $38 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $47.228B | $9.911B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $192.295B | 84.22 |
| Thermo Fisher Scientific (TMO) | United States | $152.179B | 18.41 |
| Edwards Lifesciences (EW) | United States | $43.221B | 28.34 |
| IDEXX Laboratories (IDXX) | United States | $39.543B | 45.44 |
| DexCom (DXCM) | United States | $33.200B | 51.31 |
| IQVIA Holdings (IQV) | United States | $25.775B | 14.44 |
| Mettler-Toledo (MTD) | United States | $22.466B | 26.72 |
| STERIS (STE) | Ireland | $22.247B | 25.44 |
| Waters (WAT) | United States | $20.475B | 28.89 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.744B | 0.00 |
| Hologic (HOLX) | United States | $12.646B | 13.74 |
| Penumbra (PEN) | United States | $11.514B | 90.37 |
| Sysmex ADR (SSMXY) | Japan | $11.482B | 0.00 |
| Masimo (MASI) | United States | $8.489B | 31.31 |
| Globus Medical (GMED) | United States | $7.678B | 18.01 |
| Teleflex (TFX) | United States | $5.528B | 9.13 |
| Glaukos (GKOS) | United States | $5.140B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.133B | 21.65 |
| TransMedics (TMDX) | United States | $3.771B | 81.99 |
| PROCEPT BioRobotics (PRCT) | United States | $2.939B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.402B | 14.31 |
| Veracyte (VCYT) | United States | $2.327B | 32.65 |
| Nihon Kohden (NHNKY) | Japan | $2.040B | 11.15 |
| Elekta AB (EKTAY) | Sweden | $1.943B | 17.47 |
| Alphatec Holdings (ATEC) | United States | $1.785B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.531B | 0.00 |
| Artivion (AORT) | United States | $1.235B | 115.64 |
| Pulse Biosciences (PLSE) | United States | $1.148B | 0.00 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.952B | 5.06 |
| SiBone (SIBN) | United States | $0.788B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.673B | 14.71 |
| IRadimed (IRMD) | United States | $0.659B | 33.46 |
| Beta Bionics (BBNX) | United States | $0.605B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.585B | 9.10 |
| OrthoPediatrics (KIDS) | United States | $0.535B | 0.00 |
| RxSight (RXST) | United States | $0.531B | 0.00 |
| AxoGen (AXGN) | United States | $0.518B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.517B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.473B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.429B | 0.00 |
| NeuroPace (NPCE) | United States | $0.422B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.395B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.370B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.336B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.334B | 7.09 |
| Neuronetics (STIM) | United States | $0.292B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.222B | 13.44 |
| Alpha Tau Medical (DRTS) | Israel | $0.208B | 0.00 |
| 908 Devices (MASS) | United States | $0.201B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.177B | 0.00 |
| Inogen (INGN) | United States | $0.168B | 0.00 |
| LENSAR (LNSR) | United States | $0.164B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.159B | 0.00 |
| Accuray (ARAY) | United States | $0.156B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.152B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.145B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.133B | 0.00 |
| CVRx (CVRX) | United States | $0.124B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.119B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.088B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 11.23 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.052B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 15.64 |
| Vicarious Surgical (RBOT) | United States | $0.051B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.047B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.22 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |